• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脱氧核糖核酸倍体和核形态测量在预测肾细胞癌疾病进展中的价值。

Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma.

作者信息

Ruiz-Cerdá J L, Hernández M, Gomis F, Vera C D, Kimler B F, O'Connor J E, Jiménez-Cruz F

机构信息

Department of Urology, La Fe University Hospital, Faculty of Medicine, University of Valencia, Spain.

出版信息

J Urol. 1996 Feb;155(2):459-65.

PMID:8558635
Abstract

PURPOSE

A retrospective study was performed on 108 patients with localized renal cell carcinoma (pT1 to 3a N0M0) to determine whether ploidy and nuclear morphometry are independent predictive factors in addition to stage and grade.

MATERIALS AND METHODS

Deoxyribonucleic acid (DNA) content was analyzed by flow cytometry and nuclear morphometry characterized by 5 nuclear descriptors. A Cox proportional hazards regression model was used to identify significant prognostic factors for disease progression.

RESULTS

A model combining tumor stage and grade, DNA ploidy and nuclear minor axis was chosen as optimal with risk of disease progression increased with increasing tumor stage and grade, DNA aneuploidy and increasing nuclear minor axis.

CONCLUSIONS

This improved ability to predict disease progression in localized renal cell carcinoma may have important clinical use.

摘要

目的

对108例局限性肾细胞癌(pT1至3a N0M0)患者进行回顾性研究,以确定除分期和分级外,倍性和核形态计量学是否为独立的预测因素。

材料与方法

通过流式细胞术分析脱氧核糖核酸(DNA)含量,并用5个核描述符表征核形态计量学。采用Cox比例风险回归模型确定疾病进展的显著预后因素。

结果

选择一个结合肿瘤分期和分级、DNA倍性和核短轴的模型为最佳模型,疾病进展风险随肿瘤分期和分级增加、DNA非整倍体以及核短轴增加而升高。

结论

这种在局限性肾细胞癌中预测疾病进展的能力提高可能具有重要的临床应用价值。

相似文献

1
Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma.脱氧核糖核酸倍体和核形态测量在预测肾细胞癌疾病进展中的价值。
J Urol. 1996 Feb;155(2):459-65.
2
Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.肾细胞癌中倍体、MIB-1增殖标志物和p53的预后意义。
J Am Coll Surg. 2005 Oct;201(4):565-70. doi: 10.1016/j.jamcollsurg.2005.04.018.
3
DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.DNA倍体是肾细胞癌切除术后患者预后的一个有价值的预测指标。
Cancer. 2001 Nov 1;92(9):2280-5.
4
Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
Cancer. 1996 Aug 15;78(4):819-26. doi: 10.1002/(SICI)1097-0142(19960815)78:4<819::AID-CNCR19>3.0.CO;2-Y.
5
Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.现代非转移性肾细胞癌中临床病理及脱氧核糖核酸流式细胞术变量的预后意义
Urol Oncol. 2005 Sep-Oct;23(5):328-32. doi: 10.1016/j.urolonc.2005.01.017.
6
The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.在多变量环境中,pNx/pN0分组对透明细胞肾细胞癌患者预后建模的影响。
J Urol. 2002 Jul;168(1):56-60.
7
Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.使用福尔曼分级系统对肾细胞癌观察者间最佳一致性的多中心测定:对241例随访超过15年患者的评估
Cancer. 2005 Feb 1;103(3):625-9. doi: 10.1002/cncr.20812.
8
Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy.耻骨后根治性前列腺切除术后病理局限前列腺癌患者疾病进展的危险因素分析。
J Urol. 1996 Jul;156(1):137-43.
9
Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?肾细胞癌中的Bcl-2蛋白与DNA倍性:它们会影响患者预后吗?
Int J Urol. 2005 Jun;12(6):563-9. doi: 10.1111/j.1442-2042.2005.01081.x.
10
Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
J Urol. 1996 Jun;155(6):1887-91.

引用本文的文献

1
A non-diploid DNA status is linked to poor prognosis in renal cell cancer.非整倍体 DNA 状态与肾细胞癌预后不良相关。
World J Urol. 2021 Mar;39(3):829-837. doi: 10.1007/s00345-020-03226-8. Epub 2020 May 2.
2
Evaluation of Nuclear Morphometry and Ki-67 Index in Clear Cell Renal Cell Carcinomas: a Five-Year Study.透明细胞肾细胞癌中核形态计量学与Ki-67指数的评估:一项为期五年的研究
Iran J Pathol. 2017 Spring;12(2):150-157. Epub 2017 Apr 1.